Insulet
PODD
#1005
Rank
C$27.92 B
Marketcap
$398.17
Share price
-0.14%
Change (1 day)
48.45%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.32

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.49. In 2022 the company made an earnings per share (EPS) of $0.10 a decrease over its 2021 EPS that were of $0.33.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.322195.39%
2022$0.10-69.57%
2021$0.33109.09%
2020$0.16-38.89%
2019$0.26200%
2018$0.08669-113.04%
2017-$0.66-9.8%
2016-$0.74-60.77%
2015-$1.8839.78%
2014-$1.3412.05%
2013-$1.20-23.15%
2012-$1.5610.2%
2011-$1.42-36.36%
2010-$2.22-36.63%
2009-$3.51-29.36%
2008-$4.97-86.74%
2007-$37.49-64.04%
2006-$104.24122.23%
2005-$46.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.92-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.67-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.42-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.35 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.29 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.93 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.84 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA